{"schema_version":"1","generated_at":"2026-10-30T13:46:12.068Z","data_as_of":null,"url":"https://www.findmykol.com/kol/hayder-saeed","json_url":"https://www.findmykol.com/kol/hayder-saeed/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"hayder-saeed","name":"Hayder Saeed","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Moffitt Cancer Center","institution_url":"https://www.findmykol.com/institution/moffitt-cancer-center","city":"Tampa","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1851619118","orcid":"0000-0001-5295-6088","openalex":"A5048229965"},"summary":"Hayder Saeed is an Oncology physician affiliated with Moffitt Cancer Center. OpenAlex indexes 114 publications with 1,482 citations (h-index 15); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":114,"cited_by_count":1482,"h_index":15,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05065866","title":"Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","source_url":"https://clinicaltrials.gov/study/NCT05065866","trial_url":"https://www.findmykol.com/trial/NCT05065866"},{"nct":"NCT03730363","title":"Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Reinhold Munker","source_url":"https://clinicaltrials.gov/study/NCT03730363","trial_url":"https://www.findmykol.com/trial/NCT03730363"}],"source":"trials"},"payments":{"company_count":23,"program_years":{"first":2021,"last":null},"rows_total":33,"shown":3,"withheld":30,"rows":[{"payer":"Acrotech Biopharma Inc.","program_year":2024,"amount_usd":21769.62,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851619118"},{"payer":"PFIZER INC.","program_year":2024,"amount_usd":10519.1,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851619118"},{"payer":"Incyte Corporation","program_year":2024,"amount_usd":4795,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851619118"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1851619118","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Brukinsa","share_pct":71.6},{"name":"Calquence","share_pct":28.4}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025","year":2025,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2025.0048","status":"verified"},{"title":"Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers","year":2025,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-025-01257-1","status":"verified"},{"title":"Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma","year":2024,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2405888","status":"verified"},{"title":"B‐cell maturation antigen expression and clinical features of plasmablastic lymphoma","year":2024,"journal":"eJHaem","source_url":"https://doi.org/10.1002/jha2.807","status":"verified"},{"title":"The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas","year":2024,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024012800","status":"verified"}],"source":"works"},"contact":{"address_1":"12902 USF MAGNOLIA DR","city":"Tampa","state":"FL","zip":"336129416","phone":"813-745-7365","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1851619118","source":"identity"},"similar":[{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Christine Chung","slug":"christine-chung","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/christine-chung","json_url":"https://www.findmykol.com/kol/christine-chung/profile.json"},{"name":"Jonathan Strosberg","slug":"jonathan-strosberg","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jonathan-strosberg","json_url":"https://www.findmykol.com/kol/jonathan-strosberg/profile.json"},{"name":"Nikhil Khushalani","slug":"nikhil-khushalani","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/nikhil-khushalani","json_url":"https://www.findmykol.com/kol/nikhil-khushalani/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":30,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-08-06","provider_certified":"2025-08-06","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}